Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

CNS 5Sarcoma 3Lymphoid 3Plasma cell 2Other hematologic neoplasm 2Tumor-Agnostic 1Myeloid 1Gynecologic 1Gastrointestinal 1

Conditions

Glioblastoma 4Glioma 3Astrocytoma 2Recurrence 1Oligodendroglioma 1Medulloblastoma 1Gliosarcoma 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Tetanus Toxoid × CNS × Clear all
NCT02465268 2025-01-14

ATTAC-II

University of Florida

Phase 2 Completed
175 enrolled 18 charts
CNS

Glioblastoma, Glioma

NCT00639639 2023-03-13

ATTAC

Duke University

Phase 1 Completed
42 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT02864368 2022-06-09

PERFORMANCE

Duke University

Phase 1 Terminated
27 enrolled 13 charts
CNS

Glioblastoma

NCT02747407 2021-10-29

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

Wake Forest University Health Sciences

Completed
55 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT03615404 2021-01-28

ATTAC-P

Duke University

Phase 1 Completed
11 enrolled 7 charts
CNS

Astrocytoma, Glioblastoma, Glioma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡